Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia
Lane B Benes1, Nikhil S Bassi2, Michael H Davidson1 1Department of Medicine, Section of Cardiology, 2Department of Medicine, University of Chicago, Chicago, IL, USA Abstract: The 2013 American College of Cardiology/American Heart Association guidelines on cholesterol manag...
Main Authors: | Benes LB, Bassi NS, Davidson MH |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-12-01
|
Series: | Vascular Health and Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/omega-3-carboxylic-acids-monotherapy-and-combination-with-statins-in-t-peer-reviewed-article-VHRM |
Similar Items
-
Treatment of Chinese Patients with Hypertriglyceridemia with a Pharmaceutical-Grade Preparation of Highly Purified Omega-3 Polyunsaturated Fatty Acid Ethyl Esters: Main Results of a Randomized, Double-Blind, Controlled Trial
by: Qi L, et al.
Published: (2021-09-01) -
Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated with Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
by: Ji Eun Jun, et al.
Published: (2020-02-01) -
Targeting mulitple dyslipidemias with fixed combinations – focus on extended release niacin and simvastatin
by: Anbu Pandian, et al.
Published: (2008-10-01) -
The effect of Omega 3 fatty acid on the lipid profile of hemodialysis patient
by: O. Taziki, et al.
Published: (2005-01-01) -
Elevated Triglycerides (≥150 mg/dL) and High Triglycerides (200–499 mg/dL) Are Significant Predictors of New Heart Failure Diagnosis: A Real-World Analysis of High-Risk Statin-Treated Patients
by: Toth PP, et al.
Published: (2019-12-01)